Antibody to Cytokeratin 14
<strong>Antibody to Cytokeratin 14</strong>_x000D_ <strong>Catalog number:</strong> B2015531_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 10 uL_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> 2-8°C_x000D_ <strong>Keywords:</strong> CK14;CK-14;cytokeratin 14;Cytokeratin-14;EBS3;EBS4;K14;keratin 14, type I;keratin, type I cytoskeletal 14;Keratin-14;NFJ_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Shikhman AR, Greenspan NS, Cunningham MW. Cytokeratin peptide SFGSGFGGGY mimics N-acetyl-beta-D-glucosamine in reaction with antibodies and lectins, and induces in vivo anti-carbohydrate antibody response J Immunol. 1994 Dec 15;153(12):5593-606._x000D_ 2: Atta IS. Efficacy of expressions of Arg-1, Hep Par-1, and CK19 in the diagnosis of the primary hepatocellular carcinoma subtypes and exclusion of the metastases Histol Histopathol. 2021 Sep;36(9):981-993._x000D_ 3: Kasper M, Stosiek P, Typlt H, Karsten U. Histological evaluation of three new monoclonal anti-cytokeratin antibodies. 1. Normal tissues Eur J Cancer Clin Oncol. 1987 Feb;23(2):137-47._x000D_ 4: Shadmani A, Ercal O, Uzun S, Swarup A, Wu AY. Regenerated Corneal Epithelium Expresses More βIII-Tubulin After Chemical Injuries Compared to Mechanical Injuries Transl Vis Sci Technol. 2023 Dec 1;12(12):12._x000D_ 5: Wakusawa R, Abe T, Sato H, Sonoda H, Sato M, Mitsuda Y, Takakura T, Fukushima T, Onami H, Nagai N, Ishikawa Y, Nishida K, Sato Y. Suppression of choroidal neovascularization by vasohibin-1, a vascular endothelium-derived angiogenic inhibitor Invest Ophthalmol Vis Sci. 2011 May 17;52(6):3272-80._x000D_ 6: Mancuso M, Leonardi S, Tanori M, Pasquali E, Pierdomenico M, Rebessi S, Di Majo V, Covelli V, Pazzaglia S, Saran A. Hair cycle-dependent basal cell carcinoma tumorigenesis in Ptc1neo67/+ mice exposed to radiation Cancer Res. 2006 Jul 1;66(13):6606-14._x000D_ 7: Brilot F, Jaïdane H, Geenen V, Hober D. Coxsackievirus B4 infection of murine foetal thymus organ cultures J Med Virol. 2008 Apr;80(4):659-66._x000D_ 8: Wang M, Liu A, Garcia FU, Rhim JS, Stearns ME. Growth of HPV-18 immortalized human prostatic intraepithelial neoplasia cell lines. Influence of IL-10, follistatin, activin-A, and DHT Int J Oncol. 1999 Jun;14(6):1185-95._x000D_ 9: Mete O, Kilicaslan I, Gulluoglu MG, Uysal V. Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin 1, CD63 and cytokeratin 14 antibodies in the differential diagnosis Virchows Arch. 2005 Dec;447(6):938-46._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/2472343">10: Ng HK, Lo ST. Cytokeratin immunoreactivity in gliomas Histopathology. 1989 Apr;14(4):359-68. </a>_x000D_ _x000D_ <strong>Products Related to Antibody to Cytokeratin 14 can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>
Product Specifications
CAS Number
9007-83-4
Short Description
Catalog Number: B2015531 (10 uL)
Weight
0.15
Length
2
Width
0.5
Height
0.5
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog